Advertisement

Topics

Boehringer Ingelheim Corporation Company Profile

21:49 EST 21st January 2019 | BioPortfolio

Boehringer Ingelheim Corporation based in Ridgefield, CT, is the U.S. headquarters to seven subsidiaries and a member of the Boehringer Ingelheim group of companies.


News Articles [355 Associated News Articles listed on BioPortfolio]

Boehringer Ingelheim Partners with Epizyme

Boehringer Ingelheim and Epizyme announced a partnership on Thursday to develop oncology treatments.The partnership entails developing, researching and commercializing small molecule inhibitors direct...

Deals this week: Boehringer Ingelheim, UCB, Janssen Pharmaceutical

Boehringer Ingelheim and Domain Therapeutics have entered a deal to collaborate on a drug discovery project. Both the companies have...Read More... The post Deals this week: Boehringer Ingelheim, UCB,...

Boehringer Ingelheim inaugurates new centre for agile working methods

Boehringer Ingelheim has taken an important step towards greater agility in the company with inauguration of the new building, called "BI CUBE", at the Ingelheim site. The sustainably built and innova...

Boehringer Ingelheim acquires MabVax’s programme for solid tumours

Boehringer Ingelheim has entered an asset acquisition and licence agreement for US-based biotechnology firm MabVax Therapeutics’ programme designed to target...Read More... The post Boehringer Ingel...

Boehringer investiert 128 Millionen Euro am Stammsitz Ingelheim

Der Pharmakonzern Boehringer Ingelheim hat eine weitere millionenschwere Investition am Stammsitz in Ingelheim angekündigt. Für rund 128 Millionen Euro solle bis Ende 2021 ein "Neues Technikum" en.....

Positive phase III data for adalimumab biosimilar Cyltezo

Germany-based Boehringer Ingelheim Pharmaceuticals (Boehringer Ingelheim) announced on 12 September 2018 positive phase III data for its adalimumab biosimilar, Cyltezo [1]. The results, according to B...

University of Dundee and Boehringer Ingelheim collaborate for free access of PROTAC compound on opnMe.com

Boehringer Ingelheim is to make the BET degrader compound MZ 1 available through its opnMe.com portal. The company actively supports open access in order to boost progress in biomedical and drug disco...

Boehringer Ingelheim acquires ViraTherapeutics

ViraTherapeutics, an oncolytic virus biotech, was acquired by Boehringer Ingelheim in a bid to expand its presence in the fie -More- 

Drugs and Medications [78 Associated Drugs and Medications listed on BioPortfolio]

Spiriva [Boehringer Ingelheim Pharmaceuticals Inc.]

These highlights do not include all the information needed to use SPIRIVA HANDIHALER safely and effectively. See full prescribing information for SPIRIVA HANDIHALER. SPIRIVA® HANDIHALER® (tiotropium...

Mirapex [Boehringer Ingelheim Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use MIRAPEX ER safely and effectively. See full prescribing information for MIRAPEX ER. MIRAPEX ER® (pramipexole dihydrochloride) extende...

Mobic [Boehringer Ingelheim Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use MOBIC safely and effectively. See full prescribing information for MOBIC. MOBIC® (meloxicam) tablets, for oral useInitial U.S. Approv...

Persantine [Boehringer Ingelheim Pharmaceuticals, Inc.]

Persantine®(dipyridamole USP)25 mg, 50 mg, and 75 mg tablets

Sodium citrate blood-pack units, (pl 146 plastic) [Fenwal, Inc.]

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Boehringer-Ingelheim Satellite Symposium Choosing the Right Controller Therapy in Pediatric Patients with Asthma.

Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease.

Oral inhalation is the recommended delivery method of medications for the treatment of patients with chronic obstructive pulmonary disease (COPD). However, patients may struggle when using the various...

Establishment of a CFD-based k a model in microtiter plates to support CHO cell culture scale-up during clone selection.

Microtiter plates are a common tool for clone selection in biopharmaceutical development. A way of visualizing and evaluating these systems and key processes parameters is the application of Computati...

Clinical Trials [22 Associated Clinical Trials listed on BioPortfolio]

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH & Co. KG to Boehringer Ingelheim compared to ambroxol ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions

The objective of this study was the bioequivalence of a Roxane Laboratories' Meloxicam tablets, 15 mg, to Mobic® Tablets, 15 mg (Boehringer Ingelheim) under fasting conditions using a sin...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [220 Associated Companies listed on BioPortfolio]

Boehringer Ingelheim Limited

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146...

Boehringer Ingelheim Pharmaceuticals Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group ...

Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim erforscht, entwickelt, produziert und vermarktet Arzneimittel für Menschen in aller Welt.Mit 37.406 Mitarbeitern, die in 143 Gesellschaften auf allen Kontinenten beschäftigt sin...

Boehringer Ingelheim Pharmaceuticals, Inc.

Metabolism is one of Boehringer Ingelheim's core R&D areas and diabetes is one of the indications at the center of interest within the company's global research network. Boehringer Ingelheim is commit...

Boehringer Ingelheim Corporation

Boehringer Ingelheim Corporation based in Ridgefield, CT, is the U.S. headquarters to seven subsidiaries and a member of the Boehringer Ingelheim group of companies.

More Information about "Boehringer Ingelheim Corporation" on BioPortfolio

We have published hundreds of Boehringer Ingelheim Corporation news stories on BioPortfolio along with dozens of Boehringer Ingelheim Corporation Clinical Trials and PubMed Articles about Boehringer Ingelheim Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Boehringer Ingelheim Corporation Companies in our database. You can also find out about relevant Boehringer Ingelheim Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record